These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30018981)

  • 1. Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.
    Wang Z; Li W; Guo Q; Wang Y; Ma L; Zhang X
    Biomed Res Int; 2018; 2018():6057589. PubMed ID: 30018981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of IGF system during lung injury and recovery in rats exposed to hyperoxia: a possible role of IGF-1 in alveolar epithelial cell proliferation and differentiation.
    Narasaraju TA; Chen H; Weng T; Bhaskaran M; Jin N; Chen J; Chen Z; Chinoy MR; Liu L
    J Cell Biochem; 2006 Apr; 97(5):984-98. PubMed ID: 16288470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR; Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor pathway in lung cancer.
    Dziadziuszko R; Camidge DR; Hirsch FR
    J Thorac Oncol; 2008 Aug; 3(8):815-8. PubMed ID: 18670298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan.
    Carter CS; Ramsey MM; Sonntag WE
    Trends Genet; 2002 Jun; 18(6):295-301. PubMed ID: 12044358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF) axis in cancerogenesis.
    Kasprzak A; Kwasniewski W; Adamek A; Gozdzicka-Jozefiak A
    Mutat Res Rev Mutat Res; 2017; 772():78-104. PubMed ID: 28528692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury.
    Veness-Meehan KA; Moats-Staats BM; Price WA; Stiles AD
    Am J Respir Cell Mol Biol; 1997 May; 16(5):538-48. PubMed ID: 9160836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factors and the lung.
    Stiles AD; D'Ercole AJ
    Am J Respir Cell Mol Biol; 1990 Aug; 3(2):93-100. PubMed ID: 2165791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and insulin-like growth factor-1 modulate the lipolytic action of growth hormone by altering signal pathway linkages.
    Bergan-Roller HE; Ickstadt AT; Kittilson JD; Sheridan MA
    Gen Comp Endocrinol; 2017 Jul; 248():40-48. PubMed ID: 28410970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological & physiological aspects of action of insulin-like growth factor peptide family.
    Pavelić J; Matijević T; Knezević J
    Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of insulin-like growth factor I signaling in neurodegenerative diseases.
    Trejo JL; Carro E; Garcia-Galloway E; Torres-Aleman I
    J Mol Med (Berl); 2004 Mar; 82(3):156-62. PubMed ID: 14647921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung.
    Homma S; Nagaoka I; Abe H; Takahashi K; Seyama K; Nukiwa T; Kira S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2084-9. PubMed ID: 8520779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis.
    Uh ST; Inoue Y; King TE; Chan ED; Newman LS; Riches DW
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1626-35. PubMed ID: 9817718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
    Yakar S; Leroith D; Brodt P
    Cytokine Growth Factor Rev; 2005; 16(4-5):407-20. PubMed ID: 15886048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.
    Cevenini A; Orrù S; Mancini A; Alfieri A; Buono P; Imperlini E
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J; Goldberg R; Maor G
    Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.
    Yi Y; Zeng S; Wang Z; Wu M; Ma Y; Ye X; Zhang B; Liu H
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):793-803. PubMed ID: 29253515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits.
    Savino W; de Mello-Coelho V; Dardenne M
    Neuroimmunomodulation; 1995; 2(6):313-8. PubMed ID: 8840333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.
    Põld M; Krysan K; Põld A; Dohadwala M; Heuze-Vourc'h N; Mao JT; Riedl KL; Sharma S; Dubinett SM
    Cancer Res; 2004 Sep; 64(18):6549-55. PubMed ID: 15374967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
    Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.